These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 500204)
21. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910 [TBL] [Abstract][Full Text] [Related]
22. The use of live attenuated influenza vaccine ts-1(E) in man. Gwaltney JM Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538 [TBL] [Abstract][Full Text] [Related]
24. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related]
25. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers. Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472 [TBL] [Abstract][Full Text] [Related]
26. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Ghendon YZ; Polezhaev FI; Lisovskaya KV; Medvedeva TE; Alexandrova GI; Klimov AI Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694 [TBL] [Abstract][Full Text] [Related]
27. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. Clements ML; Betts RF; Tierney EL; Murphy BR J Clin Microbiol; 1986 Jan; 23(1):73-6. PubMed ID: 3700611 [TBL] [Abstract][Full Text] [Related]
28. Temperature-sensitive mutants of influenza A virus. Transfer of the two ts-1A2 ts lesions present in the Udorn/72-ts-1A2 donor virus to the influenza A/Alaska/6/77 (H3N2) wild type virus. Murphy BR; Wood FT; Massicot JG; Chanock RM Arch Virol; 1980; 65(2):175-86. PubMed ID: 7425858 [TBL] [Abstract][Full Text] [Related]
29. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957 [TBL] [Abstract][Full Text] [Related]
30. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080 [TBL] [Abstract][Full Text] [Related]
31. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Kodihalli S; Kobasa DL; Webster RG Vaccine; 2000 May; 18(23):2592-9. PubMed ID: 10775793 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B. Farrohi K; Farrohi FK; Noble GR; Kaye HS; Kendal AP J Clin Microbiol; 1977 Mar; 5(3):353-60. PubMed ID: 323281 [TBL] [Abstract][Full Text] [Related]
33. Live bivalent vaccine for parainfluenza and influenza virus infections. Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905 [TBL] [Abstract][Full Text] [Related]
34. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909 [TBL] [Abstract][Full Text] [Related]
35. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
36. Influenza. Sabin AB Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265 [TBL] [Abstract][Full Text] [Related]
37. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. Ogra PL; Chow T; Beutner KR; Rubi E; Strussenberg J; DeMello S; Rizzone C J Infect Dis; 1977 Apr; 135(4):499-506. PubMed ID: 856917 [TBL] [Abstract][Full Text] [Related]
38. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type. Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350 [TBL] [Abstract][Full Text] [Related]
39. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. Clements ML; Murphy BR J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610 [TBL] [Abstract][Full Text] [Related]
40. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]